Analyst Ratings for Sarepta Therapeutics (SRPT) [Buys]
SRPT Rating Summary
SRPT Price Target Summary
- Highest: $224.00 (Wedbush)
- Lowest: $80.00 (Cantor Fitzgerald)
- Average: $156.60
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$156.60 (+26.3%)
* Over Last 12-Mos
Rating Score: 7.5 / 10 Percentile Rank: 80%
Rating Score: 7.5 / 10 Percentile Rank: 80%
Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|---|
1/31/2024 | BMO Capital | Kostas Biliouris | New Coverage | Outperform (N/A) |
170.00 (N/A) |
120.50 (123.97) |
2.88% | Details |
12/12/2023 | Deutsche Bank » Updated 2/29/2024 |
Neena Bitritto-Garg | New Coverage | Buy (N/A) |
156.00 (158.00) |
87.03 (123.97) |
42.45% | Details |